Q3'23 EBITDA Misses Expectations; 2023-26 Strategy Unveiled by CompanyFOREXGPW’s Analytical Coverage Support Programme 3.0
Navigating Mixed Signals: Update on Medicalgorithmics' ECG Business OutlookFOREXGPW’s Analytical Coverage Support Programme 3.0
Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime ImpactFOREXGPW’s Analytical Coverage Support Programme 3.0
Challenges and Opportunities: Bioton's 3Q23 Earnings Forecast Amidst Evolving Market DynamicsFOREXGPW’s Analytical Coverage Support Programme 3.0
Forecasts and Valuation Adjustments Following Fabrity Holding's Marketing Business SaleFOREXGPW’s Analytical Coverage Support Programme 3.0
Ailleron: Above-Average Margins, Double-Digit Earnings Growth, and Favorable ValuationFOREXGPW’s Analytical Coverage Support Programme 3.0
Initiating Coverage of Selena FM with a Buy Recommendation and PLN 40.4 Price TargetFOREXGPW’s Analytical Coverage Support Programme 3.0
ATM Grupa: Buy Rating Maintained with Caution Amidst Earnings Challenges and Growth ProspectsFOREXGPW’s Analytical Coverage Support Programme 3.0
Sensory Marketing Growth: IMS and the Closer Music ProjectFOREXGPW’s Analytical Coverage Support Programme 3.0
Unlocking Mabion's Potential: Transitioning from Biosimilars to Biologics CDMO ProviderFOREXGPW’s Analytical Coverage Support Programme 3.0
Peer Valuation: Toya's Position Among Global Power and Hand Tool ProducersFOREXGPW’s Analytical Coverage Support Programme 3.0
Valuation of Toya Shares: Applying DCF and Comparative Analysis MethodsFOREXGPW’s Analytical Coverage Support Programme 3.0
Comprehensive Valuation Analysis and BUY Recommendation for MedicalgorithmicsFOREXGPW’s Analytical Coverage Support Programme 3.0
Medicalgorithmics: A Strategic Shift Towards Growth and Innovation in the Medical Technology SectorFOREXGPW’s Analytical Coverage Support Programme 3.0
Marvipol Development Valuation: SOTP, DDM, and Multiples ApproachFOREXGPW’s Analytical Coverage Support Programme 3.0
Analyst Outlook: PLN 37.00 Target Price and 46.8% Upside PotentialFOREXGPW’s Analytical Coverage Support Programme 3.0
Navigating Uncertainty: Threats and Opportunities in Newag's OutlookFOREXGPW’s Analytical Coverage Support Programme 3.0
Positive Outlook and Strategic Advances: Artifex Mundi's Surpassing Performance and Growth ProspectsFOREXGPW’s Analytical Coverage Support Programme 3.0
Comparing to Foreign Entities: Benchmarks and ValuationFOREXGPW’s Analytical Coverage Support Programme 3.0
Initiating Coverage for Ailleron: Positive Outlook for Second Phase of ExpansionFOREXGPW’s Analytical Coverage Support Programme 3.0
Oponeo: A Successful Business Model Driving Market Share Growth and Potential ExpansionFOREXGPW’s Analytical Coverage Support Programme 3.0
SecoWarwick: Capitalizing on Electromobility, ESG, and RES Trends - Investment Opportunity AnalysisFOREXGPW’s Analytical Coverage Support Programme 3.0
Valuation of Novavis Group: DCF Method and Comparative AnalysisFOREXGPW’s Analytical Coverage Support Programme 3.0
DataWalk signs three new contracts, expects revenue decline in Q2 2023 but anticipates growth in the second half of the yearFOREXGPW’s Analytical Coverage Support Programme 3.0
Strong Performance of Surgical Robots Drives Synektik's Business Momentum and Sales GrowthFOREXGPW’s Analytical Coverage Support Programme 3.0
KGL's Strong Q1 Results Raise Earnings Forecasts, But Long-Term Concerns LingerFOREXGPW’s Analytical Coverage Support Programme 3.0
FX and Fixed Income Strategy: Navigating the Forint's Strength and Monetary Policy NormalizationECONOMYING Economics
Monnari Trade Reports Record-Breaking Quarterly Revenue Despite Challenging Market ConditionsFOREXGPW’s Analytical Coverage Support Programme 3.0
Mostostal Zabrze: Strong Financial Results and Promising Partnerships Shape a Bright FutureSTOCKSGPW’s Analytical Coverage Support Programme 3.0
BioMaxima's 1Q23 Results Fall Short of Expectations, Expansion and Development Initiatives in ProgressFOREXGPW’s Analytical Coverage Support Programme 3.0
Rebuilding Growth: Challenges and Opportunities for Fabrity in Q2 and BeyondSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Vivid Games: Challenging First Quarter Results and Funding Setback Impact ValuatioSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Profitability Under Pressure: Analyzing the Impact of Falling Grain Prices on IMC's Financial OutlookSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Aileron's 1Q23 Results: Positive Growth and Consolidation SuccessSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Surpassing Forecasts: Ambra Group's Strong Q3 Performance Sets Positive OutlookSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Surpassing Forecasts: Ambra Group's Strong Q3 Performance Sets Positive Outlook - 30.05.2023STOCKSGPW’s Analytical Coverage Support Programme 3.0